2026 Q2 Portfolio Activity
In 2026 Q2, JOHNSON & JOHNSON maintained a portfolio of 17 distinct positions.
Position History
hover any row below to update
Loading…
Total Positions
17
Quarter
2026 Q2
Top Holding
PTGX (37.6%)
Top 10 Concentration
98.4%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-17 of 17
JOHNSON & JOHNSON Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PTGX
PROTAGONIST THE...
|
Healthcare | 37.59% | 39.57% |
#1
Prev: #1
|
7.0 |
—
|
no change | no change |
P
S
|
2,449,183 | $300,220,852 | 2021 Q3 | 13F Filing | 2026-06-30 | 2026-08-06 | |||
|
NBTX
NANOBIOTIX
|
Healthcare | 26.55% | 26.61% |
#2
Prev: #2
|
6.5 |
—
|
no change | no change |
P
S
|
5,623,816 | $212,017,863 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-06 | |||
|
MGTX
MEIRAGTX HLDGS ...
|
Healthcare | 11.23% | 8.82% |
#3
Prev: #3
|
6.0 |
—
|
no change | no change |
P
S
|
6,641,064 | $89,720,775 | 2021 Q3 | 13F Filing | 2026-06-30 | 2026-08-06 | |||
|
RAPP
RAPPORT THERAPE...
|
Healthcare | 9.31% | 8.56% |
#4
Prev: #4
|
5.2 |
—
|
no change | no change |
P
S
|
1,784,517 | $74,360,823 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-06 | |||
|
CTNM
CONTINEUM THERA...
|
Healthcare | 4.06% | 3.96% |
#5
1
Prev: #6
|
3.1 |
—
|
no change | no change |
P
S
|
1,979,173 | $32,438,645 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-06 | |||
|
LEGN
LEGEND BIOTECH ...
|
Healthcare | 2.95% | 2.26% |
#6
1
Prev: #7
|
2.2 |
—
|
no change | no change |
P
S
|
814,586 | $23,525,244 | 2021 Q3 | 13F Filing | 2026-06-30 | 2026-08-06 | |||
|
CVRX
CVRX INC
|
Healthcare | 2.59% | 5.84% |
#7
2
Prev: #5
|
2.0 |
—
|
no change | no change |
P
S
|
4,024,861 | $20,687,786 | 2021 Q3 | 13F Filing | 2026-06-30 | 2026-08-06 | |||
|
XNCR
XENCOR INC
|
Healthcare | 1.51% | 1.38% |
#8
Prev: #8
|
1.6 |
—
|
no change | no change |
P
S
|
748,062 | $12,043,798 | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-06 | |||
|
N/A
CEREBRAS SYSTEM...
|
|
Unknown | 1.48% | — |
#9
Prev: #—
|
4.1 |
—
|
53,586 | — |
NEW
|
53,586 | $11,842,506 | — | 13F Filing | 2026-06-30 | 2026-08-06 | ||
|
FATE
FATE THERAPEUTI...
|
Healthcare | 1.14% | 0.62% |
#10
Prev: #10
|
1.5 |
—
|
no change | no change |
P
S
|
3,379,064 | $9,123,473 | 2021 Q3 | 13F Filing | 2026-06-30 | 2026-08-06 | |||
|
PRCT
PROCEPT BIOROBO...
|
Healthcare | 1.01% | 1.37% |
#11
2
Prev: #9
|
1.4 |
—
|
no change | no change |
P
S
|
357,939 | $8,082,263 | 2021 Q3 | 13F Filing | 2026-06-30 | 2026-08-06 | |||
|
NMRA
NEUMORA THERAPE...
|
Healthcare | 0.39% | 0.55% |
#12
1
Prev: #11
|
1.2 |
—
|
no change | no change |
P
S
|
1,849,445 | $3,144,057 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-06 | |||
|
VOR
VOR BIOPHARMA I...
|
Healthcare | 0.12% | 0.15% |
#13
Prev: #13
|
1.0 |
—
|
no change | no change |
P
S
|
53,732 | $989,206 | 2021 Q3 | 13F Filing | 2026-06-30 | 2026-08-06 | |||
|
LAB
STANDARD BIOTOO...
|
Healthcare | 0.03% | 0.04% |
#14
Prev: #14
|
1.0 |
—
|
no change | no change |
P
S
|
311,967 | $256,655 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-06 | |||
|
ACET
ADICET BIO INC
|
Healthcare | 0.02% | 0.02% |
#15
1
Prev: #16
|
1.0 |
—
|
no change | no change |
P
S
|
22,779 | $196,811 | 2021 Q3 | 13F Filing | 2026-06-30 | 2026-08-06 | |||
|
NNOX
Nano-X Imaging ...
|
Healthcare | 0.00% | 0.03% |
Sold All 😨
(Was: #15) |
0.0 |
—
|
-83,554 | -100.0% |
CLOSED
|
— | $— | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-06 | |||
|
N/A
Rallybio Corpor...
|
|
Unknown | 0.00% | 0.21% |
Sold All 😨
(Was: #12) |
0.0 |
—
|
-152,901 | -100.0% |
CLOSED
|
— | $— | — | 13F Filing | 2026-06-30 | 2026-08-06 |
Showing 1-17 of 17 holdings